Leigh Syndrome: Subgroup Aanalysis according to Mitochondrial DNA Mutation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Leigh syndrome (LS) is a rare, progressive neurodegenerative disorder with characteristic abnormalities in the central nervous system. Such patients present with heterogeneous clinical symptoms and genetic abnormalities; thus, prognosis is difficult to anticipate. The present study investigates whether distinct patient characteristics are associated with mitochondrial DNA (mtDNA) mutation in LS patients. Methods: : We retrospectively analyzed data from patients diagnosed with LS at our hospital who were assessed using genomic sequencing of mtDNA. A subgroup analysis was performed to divide patients according to the mtDNA sequencing results. Results: Among the 85 patients enrolled, 18 had mtDNA mutations. Most patients had lactic acidosis and a lactate/pyruvate ratio above 20, indicating respiratory chain abnormalities. In the subgroup analysis, the mutation group had a significantly higher female-to-male ratio, alanine level, ocular involvement, and midbrain and medulla abnormalities on magnetic resonance imaging (MRI). Conclusion: The subgroup analysis indicates that mtDNA sequencing is recommended for female patients, or those who exhibit ocular involvement, high alanine levels, or MRI findings with lesions in the midbrain and medulla.
Abstract
Purpose: Leigh syndrome (LS) is a rare, progressive neurodegenerative disorder with characteristic abnormalities in the central nervous system. Such patients present with heterogeneous clinical symptoms and genetic abnormalities; thus, prognosis is difficult to anticipate. The present study investigates whether distinct patient characteristics are associated with mitochondrial DNA (mtDNA) mutation in LS patients. Methods: : We retrospectively analyzed data from patients diagnosed with LS at our hospital who were assessed using genomic sequencing of mtDNA. A subgroup analysis was performed to divide patients according to the mtDNA sequencing results. Results: Among the 85 patients enrolled, 18 had mtDNA mutations. Most patients had lactic acidosis and a lactate/pyruvate ratio above 20, indicating respiratory chain abnormalities. In the subgroup analysis, the mutation group had a significantly higher female-to-male ratio, alanine level, ocular involvement, and midbrain and medulla abnormalities on magnetic resonance imaging (MRI). Conclusion: The subgroup analysis indicates that mtDNA sequencing is recommended for female patients, or those who exhibit ocular involvement, high alanine levels, or MRI findings with lesions in the midbrain and medulla.
참고문헌 (26)
- Leigh D, "Subacute necrotizing encephalomyelopathy in an infant", J Neurol Neurosurg Psychiatry, 14, pp.216~221 (1951)[DOI]
- Zhu Z, "SURF1, encoding a factor involved in the biogenesis of cytochrome C oxidase, is mutated in Leigh syndrome", Nat Genet, 20, pp.337~343 (1998)[DOI]
- van Erven PM, "Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature", Clin Neurol Neurosurg, 89, pp.217~230 (1987)[DOI]
- Baertling F, "A guide to diagnosis and treatment of Leigh syndrome", J Neurol Neurosurg Psychiatry, 85, pp.257~265 (2014)[DOI]
- Thorburn DR, "GeneReviews" (1993), University of Washington
- Sofou K, "A multicenter study on Leigh syndrome: disease course and predictors of survival", Orphanet J Rare Dis, 9, pp.52~ (2014)[DOI]
- Ma YY, "Genetic and biochemical findings in Chinese children with Leigh syndrome", J Clin Neurosci, 20, pp.1591~1594 (2013)[DOI]
- Rahman S, "Leigh syndrome: clinical features and biochemical and DNA abnormalities", Ann Neurol, 39, pp.343~351 (1996)[DOI]
- Lake NJ, "Leigh syndrome: one disorder, more than 75 monogenic causes", Ann Neurol, 79, pp.190~203 (2016)[DOI]
- Leshinsky-Silver E, "Fulminant neurological deterioration in a neonate with leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 gene", Biochem Biophys Res Commun, 334, pp.582~587 (2005)[DOI]
- Lim BC, "Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies", J Child Neurol, 24, pp.828~832 (2009)[DOI]
- Medina L, "MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect", AJR Am J Roentgenol, 154, pp.1269~1274 (1990)[DOI]
- Ruhoy IS, "The genetics of Leigh syndrome and its implications for clinical practice and risk management", Appl Clin Genet, 7, pp.221~234 (2014)
- Ostergaard E, "Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations", Brain, 130, pp.853~861 (2007)[DOI]
- Lee HF, "Leigh syndrome: clinical and neuroimaging follow-up", Pediatr Neurol, 40, pp.88~93 (2009)[DOI]
- Morava E, "Mitochondrial disease criteria: diagnostic applications in children", Neurology, 67, pp.1823~1826 (2006)[DOI]
- Parikh S, "Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society", Genet Med, 17, pp.689~701 (2015)[DOI]
- Janssen AJ, "Some practical aspects of providing a diagnostic service for respiratory chain defects", Annal Clin Biochem, 40, pp.3~8 (2003)[DOI]
- Stern HJ, "Lactic acidosis in paediatrics: clinical and laboratory evaluation", Ann Clin Biochem, 31, pp.410~419 (1994)[DOI]
- Stacpoole PW, "Lactic acidosis and other mitochondrial disorders", Metabolism, 46, pp.306~321 (1997)[DOI]
- Valanne L, "Neuroradiologic findings in children with mitochondrial disorders", AJNR Am J Neuroradiol, 19, pp.369~377 (1998)
- Kim J, "Neuroradiologic findings in children with mitochondrial disorder: correlation with mitochondrial respiratory chain defects", Eur Radiol, 18, pp.1741~1748 (2008)[DOI]
- Rossi A, "Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings", AJNR Am J Neuroradiol, 24, pp.1188~1191 (2003)
- Haack TB, "Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening", Mol Genet Metab, 111, pp.342~352 (2014)[DOI]
- Lieber DS, "Targeted exome sequencing of suspected mitochondrial disorders", Neurology, 80, pp.1762~1770 (2013)[DOI]
- Calvo SE, "Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing", Sci Transl Med, 4, pp.118ra10~ (2012)